Literature DB >> 25594660

Effectiveness of proton beam therapy on liver metastases of esophageal cancer: report of a case.

Hiroto Muroi1, Masanobu Nakajima, Hitoshi Satomura, Masakazu Takahashi, Yasushi Domeki, Masao Murakami, Tatsuya Nakamura, Akinori Takada, Hiroyuki Kato.   

Abstract

A 53-year-old man with multiple liver metastasis of esophageal cancer underwent four courses of chemotherapy. After four courses of chemotherapy, positron emission tomography showed progressive disease. Because it was difficult to control the cancer only by chemotherapy, we performed proton beam therapy (PBT) combined with chemotherapy. The irradiated parts were the primary tumor, liver metastases (S2/S4/S6), and mediastinal lymph nodes. The primary tumor including the mediastinal lymph nodes and the S2/S4/S6 metastases received proton beam irradiation at a total dose of 68.2 Gy in 31 fractions and 66.0 Gy in 30 fractions, respectively, according to tumor location. This resulted in a complete response as shown by positron emission tomography. In our experience, PBT exerted a curative effect on liver metastases of esophageal cancer. It is thought that PBT may be effective in the treatment of esophageal cancer. This is the first report about PBT for liver metastases of esophageal cancer.

Entities:  

Keywords:  esophageal cancer; liver metastasis; proton beam therapy

Mesh:

Substances:

Year:  2015        PMID: 25594660      PMCID: PMC4301286          DOI: 10.9738/INTSURG-D-13-00188.1

Source DB:  PubMed          Journal:  Int Surg        ISSN: 0020-8868


  9 in total

1.  Results of proton beam therapy without concurrent chemotherapy for patients with unresectable stage III non-small cell lung cancer.

Authors:  Yoshiko Oshiro; Masashi Mizumoto; Toshiyuki Okumura; Takayuki Hashimoto; Nobuyoshi Fukumitsu; Ayako Ohkawa; Ayae Kanemoto; Haruko Hashii; Toshiki Ohno; Takeji Sakae; Koji Tsuboi; Hideyuki Sakurai
Journal:  J Thorac Oncol       Date:  2012-02       Impact factor: 15.609

2.  Evaluation of liver function after proton beam therapy for hepatocellular carcinoma.

Authors:  Masashi Mizumoto; Toshiyuki Okumura; Takayuki Hashimoto; Kuniaki Fukuda; Yoshiko Oshiro; Nobuyoshi Fukumitsu; Masato Abei; Atsushi Kawaguchi; Yasutaka Hayashi; Ayako Ohkawa; Haruko Hashii; Ayae Kanemoto; Takashi Moritake; Eriko Tohno; Koji Tsuboi; Takeji Sakae; Hideyuki Sakurai
Journal:  Int J Radiat Oncol Biol Phys       Date:  2012-03-01       Impact factor: 7.038

3.  Phase II study of radiotherapy employing proton beam for hepatocellular carcinoma.

Authors:  Mitsuhiko Kawashima; Junji Furuse; Teiji Nishio; Masaru Konishi; Hiroshi Ishii; Taira Kinoshita; Michitaka Nagase; Keiji Nihei; Takashi Ogino
Journal:  J Clin Oncol       Date:  2005-03-20       Impact factor: 44.544

4.  Global cancer statistics, 2002.

Authors:  D Max Parkin; Freddie Bray; J Ferlay; Paola Pisani
Journal:  CA Cancer J Clin       Date:  2005 Mar-Apr       Impact factor: 508.702

5.  The safety and efficacy of high-dose proton beam radiotherapy for hepatocellular carcinoma: a phase 2 prospective trial.

Authors:  David A Bush; Zeid Kayali; Roger Grove; Jerry D Slater
Journal:  Cancer       Date:  2011-01-24       Impact factor: 6.860

6.  Proton beam therapy for hepatocellular carcinoma: a retrospective review of 162 patients.

Authors:  Toshiya Chiba; Koichi Tokuuye; Yasushi Matsuzaki; Shinji Sugahara; Yoshimichi Chuganji; Kenji Kagei; Junichi Shoda; Masaharu Hata; Masato Abei; Hiroshi Igaki; Naomi Tanaka; Yasuyuki Akine
Journal:  Clin Cancer Res       Date:  2005-05-15       Impact factor: 12.531

7.  Conformal radiation therapy for liver metastasis of esophageal carcinoma.

Authors:  Yoshifumi Ikeda; Masanori Niimi; Shigenao Kan; Tomoo Shatari; Hiroshi Takami; Susumu Kodaira
Journal:  Hepatogastroenterology       Date:  2003 Mar-Apr

8.  Proton beam therapy for aged patients with hepatocellular carcinoma.

Authors:  Masaharu Hata; Koichi Tokuuye; Shinji Sugahara; Eriko Tohno; Hidetsugu Nakayama; Nobuyoshi Fukumitsu; Masashi Mizumoto; Masato Abei; Junichi Shoda; Manabu Minami; Yasuyuki Akine
Journal:  Int J Radiat Oncol Biol Phys       Date:  2007-05-24       Impact factor: 7.038

9.  Proton beam therapy for hepatocellular carcinoma patients with severe cirrhosis.

Authors:  Masaharu Hata; Koichi Tokuuye; Shinji Sugahara; Nobuyoshi Fukumitsu; Takayuki Hashimoto; Kayoko Ohnishi; Keiko Nemoto; Kiyoshi Ohara; Yasushi Matsuzaki; Yasuyuki Akine
Journal:  Strahlenther Onkol       Date:  2006-12       Impact factor: 3.621

  9 in total
  4 in total

1.  Proton Beams Inhibit Proliferation of Breast Cancer Cells by Altering DNA Methylation Status.

Authors:  Byungtak Kim; Hansol Bae; Hyunkyung Lee; Seungyeon Lee; Jeong Chan Park; Kye Ryung Kim; Sun Jung Kim
Journal:  J Cancer       Date:  2016-01-10       Impact factor: 4.207

2.  Long-term survival after definitive proton beam therapy for oligorecurrent esophageal squamous cell carcinoma: a case report.

Authors:  Yojiro Ishikawa; Motohisa Suzuki; Hisashi Yamaguchi; Ichiro Seto; Masanori Machida; Yoshiaki Takagawa; Keiichi Jingu; Yasuyuki Kikuchi; Masao Murakami
Journal:  J Med Case Rep       Date:  2022-02-14

3.  Multimodality Therapy Including Proton Beam Therapy for AFP Producing Esophageal Cancer with Multiple Liver Metastases.

Authors:  Tatsuya Miyazaki; Makoto Sohda; Makoto Sakai; Yuji Kumakura; Tomonori Yoshida; Kengo Kuriyama; Takehiko Yokobori; Masaya Miyazaki; Junko Hirato; Toshiyuki Okumura; Hitoshi Ishikawa; Hideyuki Sakurai; Hiroyuki Kuwano
Journal:  Intern Med       Date:  2018-03-30       Impact factor: 1.271

4.  Survival benefit of radiotherapy in metastatic esophageal cancer: a population-based study.

Authors:  Xiangpan Li; Huibo Zhang; Xuemei Jia; Liming Xu; Huali Liu; Liang Chen; Qibin Song; Zhouguang Hui
Journal:  Transl Cancer Res       Date:  2019-08       Impact factor: 1.241

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.